# Takeda

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/takeda
Canonical HTML page: https://getyourbrief.com/entity/takeda

## Timeline

- **2026-03-18**: Quarterly Earnings Release — Official financial results and conference calls scheduled for both companies.
- **2026-03-17**: Pre-Earnings Market Activity — Both OEZVY and PTGX see increased trading volume ahead of Wednesday reports.
- **2026-02-26**: Takeda Deal Restructuring — Protagonist opts out of profit-sharing for Rusfertide in exchange for $400M cash.

## Recent coverage (1 stories, network-wide)

### Verbund and Protagonist Therapeutics Set for Key Mid-Week Earnings Reports
2026-03-17 07:34:46 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Austrian utility giant Verbund and biotech firm Protagonist Therapeutics are scheduled to release quarterly results this Wednesday. Investors will be scrutinizing Verbund's hydropower margins and Protagonist's cash position following its recent $400 million deal with Takeda.
Full story: https://getfinancebrief.com/story/verbund-protagonist-earnings-preview-march-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.